OEPSX
Price
$105.60
Change
-$2.07 (-1.92%)
Updated
Jul 2 closing price
Net Assets
10.3M
VENAX
Price
$75.19
Change
+$0.59 (+0.79%)
Updated
Jul 2 closing price
Net Assets
11.78B
Interact to see
Advertisement

OEPSX vs VENAX

OEPSX vs VENAX Comparison Chart in %
View a ticker or compare two or three
VS
OEPSX vs. VENAX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OEPSX is a Hold and VENAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VENAX has more cash in the bank: 11.8B vs. OEPSX (10.3M). VENAX pays higher dividends than OEPSX: VENAX (2.68) vs OEPSX (0.00). OEPSX was incepted earlier than VENAX: OEPSX (20 years) vs VENAX (22 years). OEPSX (2.74) is less costly to investors than VENAX (0.09). OEPSX is a more actively managed with annual turnover of: 149.00 vs. VENAX (11.00). OEPSX has a lower initial minimum investment than VENAX: OEPSX (15000) vs VENAX (100000). OEPSX annual gain was more profitable for investors over the last year : 89.35 vs. VENAX (23.36). VENAX return over 5 years is better than : 96.23 vs. OEPSX (49.26).
OEPSXVENAXOEPSX / VENAX
Total Expense Ratio2.740.093,044%
Annual Report Gross Expense Ratio2.740.093,044%
Fund Existence20 years22 years-
Gain YTD44.10519.520226%
Front LoadN/AN/A-
Min. Initial Investment1500010000015%
Min. Initial Investment IRAN/AN/A-
Net Assets10.3M11.8B0%
Annual Yield % from dividends0.002.68-
Returns for 1 year89.3523.36382%
Returns for 3 years25.9433.0079%
Returns for 5 years49.2696.2351%
Returns for 10 years-72.9157.71-126%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX57.551.06
+1.88%
Eventide Healthcare & Life Sciences N
BSCAX24.310.09
+0.37%
Brandes Small Cap Value A
LEGCX53.02-0.56
-1.05%
Columbia Cornerstone Growth C
KGDAX35.37-0.43
-1.20%
DWS Global Small Cap A
NQCFX34.12-0.50
-1.44%
NorthQuest Capital